Table 1.
Correlation between baseline parameters and occurrence of HCCs, mortality, liver transplantation and total clinical events during follow-up analysed by univariate logistic regression
| HCC | Mortality | Liver transplantation | Total events | |
|---|---|---|---|---|
| Cirrhosis | 0.0014 | 0.0150 | 1.0000 | 0.0046 |
| Male sex | 0.4106 | 0.4106 | 1.0000 | 0.4663 |
| NUC treatment | 0.0042 | 0.0497 | 0.4902 | 0.0049 |
| Interferon treatment | 0.0198 | 0.0198 | 1.0000 | 0.0379 |
| HDV PCR positive | 1.0000 | 0.6869 | 1.0000 | 1.0000 |
| HDV genotype | 0.4104 | 0.4104 | 0.9891 | 0.7423 |
| HDV-RNA (IU/ml) | 0.8004 | 0.1446 | 0.4018 | 0.3493 |
| HBV-DNA (IU/ml) | 0.7417 | 0.9507 | 0.6855 | 0.8138 |
| HBeAg-pos | 0.1001 | 0.0065 | 1.0000 | 0.0422 |
| HBsAg (IU/ml) | 0.9633 | 0.7851 | 0.9642 | 0.8285 |
| Albumin (g/L) | 0.1222 | 0.1291 | 0.9412 | 0.2454 |
| INR | 0.0057 | 0.0181 | 0.0878 | 0.0037 |
| Platelet count (109/L) | 0.0063 | 0.0259 | 0.1436 | 0.0036 |
| Bilirubin (mg/dl) | 0.0203 | 0.0019 | 0.8724 | 0.0027 |
| MELD score | 0.0062 | 0.0092 | 0.1153 | 0.0026 |
| ALT (U/L) | 0.5156 | 0.6844 | 0.6294 | 0.5339 |
| AST (U/L) | 0.6483 | 0.3476 | 0.9362 | 0.3322 |
| yGT (U/L) | 0.4852 | 0.4343 | 0.1767 | 0.2102 |
| Age | 0.0880 | 0.0633 | 0.7643 | 0.0395 |